SCIENTURE HOLDINGS, INC. Deferred Income Tax Assets, Net
SCIENTURE HOLDINGS, INC. (SCNX) had Deferred Income Tax Assets, Net of $534.40 thousand as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-03-30
- 2025-09-30: Deferred Income Tax Assets, Net $534.40K.
- 2025-06-30: Deferred Income Tax Assets, Net $534.40K.
- 2025-03-31: Deferred Income Tax Assets, Net $534.40K.
- 2024-12-31: Deferred Income Tax Assets, Net $534.40K.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2025-09-30 | $534.40K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $534.40K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $534.40K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $534.40K 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |